Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
97.64
-0.93 (-0.94%)
Dec 16, 2025, 1:45 PM EST - Market open
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 13.09B | 12.76B | 12.48B | 12.28B | 12.17B | 11.99B | 11.83B | 12.00B | ||||||||||||
| Cardiovascular Growth | 7.61% | 6.43% | 5.49% | 2.27% | 2.71% | 2.50% | 2.35% | 7.00% | ||||||||||||
| Neuroscience | 10.06B | 9.95B | 9.85B | 9.77B | 9.67B | 9.51B | 9.41B | 9.27B | ||||||||||||
| Neuroscience Growth | 4.01% | 4.63% | 4.67% | 5.38% | 5.49% | 4.88% | 5.00% | 4.79% | ||||||||||||
| Medical Surgery | 8.54B | 8.50B | 8.41B | 8.39B | 8.47B | 8.48B | 8.53B | 8.45B | ||||||||||||
| Medical Surgery Growth | 0.80% | 0.13% | -1.40% | -0.70% | 0.33% | 1.36% | 2.34% | 0.17% | ||||||||||||
| Diabetes | 2.90B | 2.83B | 2.76B | 2.69B | 2.63B | 2.56B | 2.49B | 2.42B | ||||||||||||
| Diabetes Growth | 10.14% | 10.64% | 10.73% | 10.90% | 11.90% | 11.22% | 9.99% | 7.02% |
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 17.52B | 17.31B | 17.17B | 16.97B | 16.85B | 16.72B | 16.56B | 16.70B | ||||||||||||||||||||||
| United States Growth | 4.01% | 3.54% | 3.67% | 1.62% | 1.27% | 1.14% | 1.15% | 4.38% | ||||||||||||||||||||||
| Rest of World | 17.23B | 16.89B | 16.37B | 16.23B | 16.15B | 15.86B | 15.80B | 15.62B | ||||||||||||||||||||||
| Rest of World Growth | 6.74% | 6.51% | 3.58% | 3.90% | 5.40% | 5.52% | 6.38% | 5.72% |
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 11.21B | 11.00B | 10.85B | 10.89B | 10.85B | 10.78B | 10.74B | 10.59B | |||||||
| Selling, General, and Administrative Growth | 3.31% | 2.06% | 1.05% | 2.89% | 3.04% | 3.04% | 3.09% | 2.12% | |||||||
| Research and Development | 2.84B | 2.78B | 2.73B | 2.72B | 2.74B | 2.74B | 2.74B | 2.70B | |||||||
| Research and Development Growth | 3.50% | 1.38% | -0.15% | 0.81% | 1.82% | 2.69% | 1.48% | -0.26% | |||||||
| Amortization | 1.90B | 1.85B | 1.81B | 1.66B | 1.67B | 1.68B | 1.69B | 1.70B | |||||||
| Amortization Growth | 14.23% | 10.44% | 6.80% | -2.00% | -2.52% | -1.58% | -0.35% | -0.82% | |||||||
| Litigation | - | 344.00M | 361.00M | 212.00M | - | 230.00M | 119.00M | - | 110.00M | 79.00M | 65.00M | - | - | - | - |
| Litigation Growth | - | 189.08% | 228.18% | 168.35% | - | 253.85% | - | - | - | - | - | - | - | - | - |
| Restructuring | 245.00M | 265.00M | 267.00M | 232.00M | 209.00M | 219.00M | 226.00M | 408.00M | |||||||
| Restructuring Growth | 17.22% | 21.00% | 18.14% | -43.14% | -50.94% | -47.36% | -39.89% | 270.91% | |||||||
| Other Expenses | 102.00M | 46.00M | -23.00M | 439.00M | 461.00M | 464.00M | 464.00M | 43.00M | |||||||
| Other Expenses Growth | -77.87% | -90.09% | - | 920.93% | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.